{"name":"Suzhou Genhouse Bio Co., Ltd.","slug":"suzhou-genhouse-bio-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"BRAF Inhibito","genericName":"BRAF Inhibito","slug":"braf-inhibito","indication":"Other","status":"phase_2"},{"name":"GH21 Capsule","genericName":"GH21 Capsule","slug":"gh21-capsule","indication":"Growth hormone deficiency in children","status":"phase_2"},{"name":"MET inhibitor","genericName":"MET inhibitor","slug":"met-inhibitor","indication":"Other","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Tagrisso","genericName":"Tagrisso","slug":"tagrisso","indication":"Non-small cell lung cancer, positive for epidermal growth factor receptor expression","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"phase II","genericName":"phase II","slug":"phase-ii","indication":"Type 2 diabetes","status":"marketed"}]}],"pipeline":[{"name":"BRAF Inhibito","genericName":"BRAF Inhibito","slug":"braf-inhibito","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GH21 Capsule","genericName":"GH21 Capsule","slug":"gh21-capsule","phase":"phase_2","mechanism":"GH21 Capsule is a growth hormone analogue used to treat growth hormone deficiency.","indications":["Growth hormone deficiency in children"],"catalyst":""},{"name":"MET inhibitor","genericName":"MET inhibitor","slug":"met-inhibitor","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tagrisso","genericName":"Tagrisso","slug":"tagrisso","phase":"marketed","mechanism":"Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma, Cysteine--tRNA ligase, cytoplasmic, Dipeptidyl peptidase 1","indications":["Non-small cell lung cancer, positive for epidermal growth factor receptor expression"],"catalyst":""},{"name":"phase II","genericName":"phase II","slug":"phase-ii","phase":"marketed","mechanism":"This drug works by inhibiting the activity of a specific enzyme.","indications":["Type 2 diabetes","Heart failure"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPS1FWQzdZWno3S2MzeEl1d1lMMUlwVV9lVW5ZZnlqcDNGYUpGLWtoLWpsV09mSEg5UFNNTmVLbHdvR09hcFlnZGFoSW10UEtzZW5QU2RQTU9JMlJNT3hRMnQxVE5CMEZuNWlaaDZMS0RkbGhLR05rMktDV01xSUtUYUtfYXUwSHJRV3c?oc=5","date":"2026-02-20","type":"pipeline","source":"Medical Marketing and Media","summary":"Rx Rundown: Danaher, Johnson & Johnson, Bayer and more - Medical Marketing and Media","headline":"Rx Rundown: Danaher, Johnson & Johnson, Bayer and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNODdrbjVQREpWN1Q4Vk5qNDQ4ekROMjdCck5BWWlwY0Q1Y0Z5cWlEUE5xZWpiS2g5X3RuSDJMTUREdFF4dmVDWEp2THdtOWJHSkxxYjNOTm40bjY4MEFoQ1JLZ2xWbk5iOHppNTZ1LUdfems1OEdGeEd2V0pweVFoUDlpcERDbFYtQ2VfSnF0RVd2WlFSZkgyWFJHWmZzcG8?oc=5","date":"2026-02-18","type":"deal","source":"BioWorld News","summary":"Gilead-Genhouse's $1.5B+ deal boosts synthetic lethality push - BioWorld News","headline":"Gilead-Genhouse's $1.5B+ deal boosts synthetic lethality push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOak9zM3hlMXY2RmplTVFEOXprb0ZLbXI1NnpXTzBFWmwtTUU4cVZLRzRpRVFqV1l1VzBwZ1hQQjJYMnJYU0tIU0dpRElseTVxcUlZREhBOTNGR0UyamFaMFduak1POW5vemYyMWhGNWU3V0ltbHprREtlVVhNS3F4TkthZEF3SDY2T2ZBV3U5UFNJWWxBWjBDNUttWlZsb3dxSmwzMWF4cmdmb1hy?oc=5","date":"2026-02-17","type":"deal","source":"BioCentury","summary":"Gilead-Genhouse tie-up among several spanning Pacific: Deals Report - BioCentury","headline":"Gilead-Genhouse tie-up among several spanning Pacific: Deals Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxONFlrSXJZSi1JWXlxa3k0NjhBWFNNVkV0cV9RYUVkOTA2QUluNU9FcTgtMy0ySjhtQjZNVmhUTHY1eXdQQzdBbHhmX2JtMXZHQ0tlUGgxMko4R3Y0NDFjNF96ZVpZX3lSbEwwQ0NnMXVyMlMxVWxUUnZxaHhldEw4aHBTYkd1Nm1sQzhaVlhGUVRIa3lfUXU4OGJtOVp3TTVPOWNxaHVOOEhUZFlr?oc=5","date":"2026-02-16","type":"deal","source":"Fierce Biotech","summary":"Gilead's latest synthetic lethal therapy comes via $1.5B deal with China's Genhouse - Fierce Biotech","headline":"Gilead's latest synthetic lethal therapy comes via $1.5B deal with China's Genhouse","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9MS3pFY2hXZW9UTkZoLUpVeV9UaUlNc3dKTDlHalFUUXdzeHctNGcxUzhnY3o1VWttMmFiV0d4dFBQLXk3TF9MN3Y1ZlJkaWdxYncw?oc=5","date":"2026-02-13","type":"deal","source":"FirstWord Pharma","summary":"Biopharma bites: Layoffs at Ultragenyx, Gilead's licensing deal, plus a pair of PIPEs and a 340B update - FirstWord Pharma","headline":"Biopharma bites: Layoffs at Ultragenyx, Gilead's licensing deal, plus a pair of PIPEs and a 340B update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNaU01NV9VZlV2VWZKNThwem4xN3BTSkhSS1BzZjZTc3BmeWFVTVNmeWk3U0cwYzRLRGVGaVdJcFpBWTNvX2JkcXVyUE9vUVhHczhqX21ZWGphbzNQSUFkZHVYcTlhZVNBNFREYnFHMjNCdER4OTJXdkZQZWZZajg4SnJVc3Vpazh1QjZtTzlETFQycGNlR3M0d0l4MlczQ0ZtZDZV?oc=5","date":"2025-12-10","type":"trial","source":"BioWorld News","summary":"D3 Bio raises $108M series B to move KRAS G12C into phase III - BioWorld News","headline":"D3 Bio raises $108M series B to move KRAS G12C into phase III","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQdENpN2hCZFlzMFRmd3FyRm1QQkUtOFR3bGFvNXp4N0hydlM4XzUwYXV6SXhRbEdKbTI2VEJNUnRqbWRyMnZwMTU3NWJHUmRGeW5xV0lrdHBNZXE0bUZWRHpMUmlZUUFKOFJxc1ZHekZRVFBjRDgwaEttZHhtdlJfY0FUVGVDNUpRX1gzbmxwYjVPcEt1dE9UMGFQZGw?oc=5","date":"2025-07-22","type":"pipeline","source":"BioWorld News","summary":"Suzhou Genhouse Bio discloses WRN inhibitors for cancer - BioWorld News","headline":"Suzhou Genhouse Bio discloses WRN inhibitors for cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQOG5sZEpjUzZkYzhvUUl0YVh3QjFuTVdsREQ0SnB0X0trN0NEbmw0Z2ZnZ296dWhQalE1OFNIdHZGYUZ2Q0lIQTQxUElFNWlnbU11dFJWcVQ5Wk12ZWpQaGJyVUZSWnB4NFA0ZXR3TXNIZVNXTFNGb0MtMEl2OC1BaE1NV2xKVnhHM0xJYmpnNVZ5eWUxbDlFczdDaGR3RGV2QlQ0THZkM0RuZ29qZW1kMjcyVGI?oc=5","date":"2024-04-12","type":"pipeline","source":"Seeking Alpha","summary":"Revolution Medicines: An Expensive Shot At A Massive Market Opportunity (NASDAQ:RVMD) - Seeking Alpha","headline":"Revolution Medicines: An Expensive Shot At A Massive Market Opportunity (NASDAQ:RVMD)","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_2":3,"marketed":2},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}